Latest Daily News

Latest News
June 3, 2017

With appropriate oversight by regulatory authorities, professional organizations such as ASCO, and patient and clinician education programs, we will see the potential for considerable cost savings and increased access and equity of cancer care through the use of biosimilars.

Read more